Investigation of lipid status and its association with postoperative outcomes in patients with peripheral arterial disease, carotid artery stenosis, or aortic pathologies undergoing vascular surgical treatment, including assessment of the achievement of guideline-recommended LDL cholesterol target levels.
Conditions
Interventions
Group 1: Prospective, single-center observational study in patients undergoing vascular surgical treatment. Baseline data (lipid levels, medication, clinical parameters) are collected at hospital admi
Sponsors
Klinik für Gefäß- und Endovaskularchirurgie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Hospitalized patients undergoing vascular surgical care (conservative, interventional, or surgical treatment) Ability to provide informed consent Sufficient understanding of the German language to participate in the study
Exclusion criteria
Exclusion criteria: Inability to provide informed consent (e.g., due to language barriers or impaired capacity) Emergency treatment situation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of LDL cholesterol levels at hospital admission and determination of the proportion of patients achieving guideline-recommended target levels. Association between LDL cholesterol levels and postoperative outcomes: Analysis of the relationship between baseline LDL cholesterol levels and postoperative outcomes, including complications, reinterventions, rehospitalizations, and mortality. Methods of assessment: Baseline data collection and follow-up over 12 months using laboratory data, medical records, and standardized questionnaires. Time points: Baseline and follow-up up to 12 months postoperatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison between patients with and without cardiologic comorbidities regarding LDL levels, treatment strategies, and target achievement Assessment of lipid-lowering therapy (type, dosage, modifications) and medication adherence Analysis of factors influencing LDL target attainment (e.g., age, sex, comorbidities) Methods of assessment: Medical records, laboratory data, and standardized questionnaires. Time points: Baseline and follow-up up to 12 months. | — |
Countries
Germany
Outcome results
None listed